Clinical Trial Update: Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tofacitinib or etanercept for speeding NSAID tapering and guiding corticosteroid de-escalation in rheumatoid arthritis using a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Dr. Frank Behrens | Conditions: Rheumatic Arthritis | Phase 4 | Status: COMPLETED